PACS Group, Inc. (PACS)

The investment case for PACS is currently broken by a catastrophic multi-year price trajectory. Despite the company reporting positive earnings growth and a forward P/E that looks attractive in isolation, the stock has lost nearly 70% of its value over the last year, with the most recent annual return being a steep -69.9%. This massive capital destruction signals that the market has priced in severe structural issues, likely related to the regulatory scrutiny mentioned in recent headlines regarding Colorado care standards. The balance sheet is fragile, carrying debt-to-equity of over 300x, which makes the business highly sensitive to any operational hiccups or further legal costs. While the recent price action shows a slight bounce off lows, the overwhelming options activity—specifically the wall of open interest in deep out-of-the-money puts—indicates that smart money is still betting against the stock or hedging against further ruin. There is no dividend to provide income, and the fundamental deterioration is too severe to ignore. This is a 'value trap' where the cheap price reflects a dying business, not a bargain.